Official clinic pages and public records where available.
Public source checks
The rows below standardise what was and was not confirmed from the reviewed public sources.
How to read these checks: ✓ Confirmed · ◐ Partial · — Not confirmed
Comparison checklist
How to read this checklist: ✓ Yes · ◐ Partial · — Not confirmed
Identity and regulatory checks
The links below are neutral reference points, not approval signals. They show what could be confirmed directly from the clinic’s own public pages at review time.
Aestha’s public trail is now stronger than a single service page. The peptide page gives the core treatment framing, the contact page lists 21 Welbeck St, Marylebone, London W1G 8EE with direct email and phone details, the homepage schema presents Aestha as a MedicalClinic, and the About page publicly names Dr. Shatha Taha, MBBS.
What this profile still does not establish is a direct regulator or legal-entity match. No confirmed Companies House record, CQC provider page, GMC register profile, or named GPhC dispensing route was safely matched from the reviewed public trail, so the Welbeck Street address should still be read as a strong clinic contact trail rather than a fully regulator-linked verification chain.
- Official peptide page ↗ — public page reviewed for the peptide service description
- About Aestha ↗ — reviewed for named clinician trail
- Official contact page ↗ — reviewed for Welbeck Street address, phone, and email
- Homepage ↗ — reviewed for MedicalClinic schema and wider clinic identity
This record is publishable and materially stronger than a bare minimal-reference listing, but legal-entity and regulator checks should stay open until stronger public evidence appears. See our methodology for record status definitions.
Public address trail reviewed: 21 Welbeck Street, London W1G 8EE
The public trail supports a postcode-area marker rather than a clinic-entrance confirmation.
Please confirm the address before visiting.
Questions to ask before booking
Because Aestha’s peptide page is stronger on service description than on public verification detail, these questions are worth asking directly:
- Who is the named prescribing or supervising clinician for peptide treatments?
- Can the clinic point you to the relevant GMC registration for the clinician overseeing care?
- What consultation, testing, and follow-up steps happen before a peptide plan is approved?
- Which peptide products are actually prescribed, and through which pharmacy are they supplied?
- Can the clinic confirm the exact public business identity behind the Welbeck Street address?
- How are side effects, review intervals, and stopping criteria handled in practice?